Financial news recaps

S&P 500

92 APP APP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds ... Class action Lawsuit AI-generated analysis
  • ⚖️ Federal lawsuit alleges false statements about AI timelines and overstated reliability.
  • 📉 Stock fell 12.65% on July 13 amid muted ad growth concerns.
  • 💸 Shares dropped another 19.66% after Q2 revenue missed consensus by $20M.
 88 CSCO Why Is Cisco Stock Falling Today Despite Higher Quarterly Revenue and Earnings? AI infrastructure Analyst downgrade Earnings report AI-generated analysis
  • 📉 CSCO shares fell 2% premarket despite beating Q1 2027 revenue and earnings estimates.
  • 💰 Fiscal Q1 2027 revenue hit record $18.52 billion, up 24% year-over-year.
  • 🤖 Cisco doubled fiscal 2027 AI infrastructure revenue target to $9 billion.
 88 ANET What Did Arista Networks Stock Investors Miss Before The Run? AI integration Company update AI-generated analysis
  • 📈 ANET stock returned 53.1% over twelve months ending November 2026.
  • 🚀 Revenue grew 58.5% year-over-year in Q3 2026, a record pace.
  • 💰 Management met and exceeded $750 million AI back-end cluster sales goal.
 85 COR Cencora stock sets specialty-led path for fiscal 2027 Acquisition Company update Dividend AI-generated analysis
  • 📈 Q4 revenue rose 5.5% to $88.4 billion.
  • 💰 Adjusted EPS surged 21.4% to $4.66.
  • 🔄 Specialty services expected to grow 9-14%.
 82 TPR Is Wall Street Bullish or Bearish on Tapestry Stock? Analyst downgrade Earnings report AI-generated analysis
  • 📈 Q1 revenue grew 12.1% YoY to $1.9 billion, beating estimates.
  • 💰 Adjusted EPS hit $1.82, surpassing analyst expectations.
  • 🚀 Full-year guidance raised with revenue midpoint now $8.6 billion.

Data centers

88 ANET What Did Arista Networks Stock Investors Miss Before The Run? AI integration Company update AI-generated analysis
  • 📈 ANET stock returned 53.1% over twelve months ending November 2026.
  • 🚀 Revenue grew 58.5% year-over-year in Q3 2026, a record pace.
  • 💰 Management met and exceeded $750 million AI back-end cluster sales goal.
 72 SMCI Super Micro Stock Bounces Back After a Denial Involving Megaspeed Company update Regulatory investigation AI-generated analysis
  • 📈 Shares rose 1.7% after-hours following denial of Megaspeed customer status.
  • 💰 Q1 revenue surged nearly fourfold to $19.9 billion year-over-year.
  • 📊 Adjusted gross margins expanded significantly to 12.8% from 9.5%.
 92 ANET Arista Networks Stock: Is Wall Street Bullish or Bearish? AI infrastructure Analyst upgrade Earnings report AI-generated analysis
  • 📈 ANET shares up 45.8% in 52 weeks, outpacing S&P 500.
  • 💰 Q3 revenue surged 58.5% YoY to $3.66 billion.
  • 🚀 Non-GAAP operating income jumped 60.1% to $1.80 billion.
 88 DELL Was The Run In Dell Stock Hiding In Plain Sight? AI infrastructure Company update Earnings report AI-generated analysis
  • 📈 Dell shares surged 39.0% May-November 2025 on strong data center demand signals.
  • 💰 Revenue accelerated to 39.5% YoY, reaching $47.0 billion by July 2026.
  • 🖥️ Infrastructure Solutions Group hit record $31.8 billion revenue in Q3 fiscal 2026.
 82 VRT Vertiv stock sees AI power roadmap sharpen at Baird conference AI infrastructure Capacity expansion Company update AI-generated analysis
  • 📈 Resilient AI demand confirmed across hyperscalers and enterprises at Baird 2026.
  • 💰 Revenue surged from $4B in 2020 to ~$14.5B by 2026.
  • 🔋 Hybrid 800-VDC systems launching H2 2027 for high-density computing.

Biotech / Genomics

78 MRNA The Single Most Important Metric For Moderna Stock Company update Earnings report Guidance raised AI-generated analysis
  • 📈 Moderna raised 2026 revenue growth outlook to 15-25% driven by international performance.
  • 🌍 International revenue hit $900M in Q3, exceeding full-year 2025 totals and reaching 40% of sales.
  • 💰 Operating profit turned positive at $0.13B in Q3 after a $0.26B loss last year.
 82 MRNA "More Cancers Than Melanoma": Moderna Is Up 750% in 2026. Take Profits ... Clinical trial results Company update Drug approval AI-generated analysis
  • 📈 Moderna stock gained 750% in 2026 driven by Intsimeran Phase 3 success.
  • 💰 Q3 revenue rose 29% to $1.31B with a $162M profit posted.
  • 🔬 Intsimeran cut recurrence/death risk by 42% versus Keytruda alone.
 88 MRNA Why Did U, MRNA, ABNB Stocks Surge To 52-Week Highs Today? Analyst upgrade Earnings report AI-generated analysis
  • 📈 Moderna stock surged to a near five-year high of $280.80 on strong Q3 earnings.
  • 💰 Company posted first profitable quarter in two years with $162 million net income.
  • 📊 Revenue advanced 29% year-over-year to $1.31 billion driven by international vaccine sales.
 78 MRNA BioNTech vs. Moderna: The COVID Vaccine Giants Are Entering a New Era. One Stock Could Have the Edge for 2027 Clinical trial results Company update Drug approval AI-generated analysis
  • 📈 BioNTech grew FY 2025 revenue 4.3% to $3.2B showing market resilience.
  • 💰 MRNA holds €16.2B cash with zero debt offering strong financial flexibility.
  • 📉 MRNA revenue fell 40% in FY 2025 due to weak COVID vaccine sales.
 92 REGN Regeneron stock weighs Q3 growth and broader Sanofi alliance Earnings report Licensing agreement AI-generated analysis
  • 📈 Q3 revenue hit $5.1 billion, up 36% year-over-year.
  • 💰 Non-GAAP EPS surged 70% to $20.07.
  • 🤝 Sanofi alliance adds four antibodies with $1B upfront payment.

Cybersecurity

82 PANW What Palo Alto Networks Stock Upgrade Means For Shareholders AI integration Acquisition Company update AI-generated analysis
  • 🤝 Palo Alto Networks pursues $500M acquisition of Clutch Security for AI capabilities.
  • 🔄 Integrates Prisma Browser into Guardz to bolster small business protection.
  • 🚀 Prisma AIRS hits $100M ARR in four quarters, fastest ramp ever.
 78 CRWD CrowdStrike and Palo Alto Networks Climb 3% as Microsoft Outage Disrupts Outlook and Teams AI integration Company update New AI features AI-generated analysis
  • 📈 Stock jumped 3% as investors bet Microsoft outage drives demand for independent security platforms.
  • 🚀 Shares up 102% YTD following record Q2 FY2027 revenue of $1.47 billion.
  • 💼 Falcon platform works across Azure, offering independence buyers seek after vendor disruptions.
 92 FTNT Fortinet stock tracks stronger outlook after Q3 growth Earnings report Guidance raised AI-generated analysis
  • 📈 Q3 revenue surged 20% YoY to $2.078 billion.
  • 💰 Billings jumped 29% to $2.336 billion.
  • 🚀 Raised full-year outlook for revenue and EPS.
 82 NET What Did Cloudflare Stock Investors Miss Before The Run? AI integration New features AI-generated analysis
  • 📈 NET stock surged 63.5% from May to November 2026, outpacing S&P 500.
  • 💰 Revenue growth accelerated from 26.5% in Q1 2025 to 33.6% in Q4 2025.
  • 🤖 Workers Platform and AI workloads drove recent sales acceleration for NET.
 78 PANW Palo Alto Networks (PANW) Stock Looks Reasonably Priced Despite AI Deal Talk AI integration Acquisition Company update AI-generated analysis
  • 📈 PANW delivered 290.6% five-year return despite recent pullback.
  • 💰 Company pursues $500M cash acquisition of Clutch for AI.
  • 📊 Generated $4.2B free cash flow with $13.2B by 2031.

Big Pharma

78 ABBV AbbVie is Outperforming the Market this Year So Far. Is Its 16.4x Valuation Attractive? Acquisition Earnings report AI-generated analysis
  • 📈 Shares surged 23% YTD as investors assess AbbVie's transition strategy.
  • 💊 Skyrizi and Rinvoq drove $8.79B immunology revenue, offsetting Humira decline.
  • 🧠 Neuroscience portfolio grew 20.3% to $3.23B in the second quarter.
 68 BMY Bristol Myers Squibb (BMY) Stock Looks Below Fair Value Following A 41% ... Drug approval Earnings report Financial outlook AI-generated analysis
  • 📈 BMY stock returned 40.5% over three years, trading near $62.91.
  • 💰 Company generated $9.3 billion in free cash flow last twelve months.
  • 🔬 Positive data for Camzyos and ZENBEXUS approvals support future cash flows.
 92 LLY Eli Lilly (LLY) Stock Climbs as China Approves First GLP-1 Weight-Loss Pill Drug approval Market expansion AI-generated analysis
  • 🚀 Eli Lilly stock surged 3% to a record high after China approved orforglipron (Foundayo).
  • 🏆 Foundayo approval positions Lilly ahead of Novo Nordisk for oral GLP-1 clearance in China.
  • 💊 The new therapy offers a once-daily, non-injection alternative appealing to patients avoiding needles.
 85 AMGN Is Amgen Stock Priced Right Against Its Peers? Financial outlook AI-generated analysis
  • 📊 AMGN ranks second among six major drugmakers in revenue growth and operating margins.
  • 💰 Investors pay 27x earnings for AMGN versus 42x for Johnson & Johnson.
  • 🚀 Six core medicines drove a 27% year-over-year growth in product sales.
 78 BMY Bristol Myers Squibb (BMY) Stock Looks Below Fair Value Following A 41% Run Drug approval Earnings report Financial outlook AI-generated analysis
  • 📈 BMY shares gained 40.5% over three years, trading at US$62.91.
  • 💰 Company generated roughly $9.3 billion in free cash flow last year.
  • 📉 Revenue expected to decline from Eliquis starting in 2027.

Big Tech and AI

82 ORCL Oracle Rallies 6% as $20 Billion Stock and Bond Sale Clears Funding Overhang; CoreWeave Climbs 7%, Microsoft Gains 2% Capital raising Cloud expansion AI-generated analysis
  • 📈 Oracle stock rallied 6% after successfully pricing a $20 billion capital raise.
  • 💰 Company sold 86.2 million shares and issued senior notes with coupons up to 8.65%.
  • 📉 Interest expense surged 55% YoY to $1.4 billion while Q1 free cash flow hit -$5.4 billion.
 82 AVGO Broadcom Stock Tumbles 7% as Redburn Downgrade Flags $43 Billion AI Backstop Risk, Ending a 25% Rally Analyst downgrade Financial outlook AI-generated analysis
  • 📉 Rothschild downgraded AVGO to Neutral, cutting price target by 33% to $398.
  • ⚠️ Concerns focus on $43B contingent liability if Anthropic fails AI data center leases.
  • 📈 AI semiconductor revenue surged 221% YoY to $16.7 billion in the last quarter.
 78 META Meta Platforms (NASDAQ:META) stock surges as AI spending leads earnings week AI infrastructure AI integration Company update AI-generated analysis
  • 📈 Meta stock surges on record AI infrastructure spending plans.
  • 🏗️ Company commits vast sums to data-center construction projects.
  • 💰 Ad revenue funds aggressive expansion into artificial intelligence.
 78 AMD Why Are Advanced Micro Devices (AMD) Shares Drawing Fresh AI Attention? AI infrastructure Chip design win Company update AI-generated analysis
  • 📈 Shares rose 5% as investors rotated capital toward rivals following Nvidia CEO resignation.
  • 🚀 Launched 6th Gen EPYC SP7 processors targeting agentic AI workloads and Helios racks.
  • 🤝 Secured major design wins with Google Cloud, Meta, Microsoft Azure, and Oracle.
 78 NVDA Nvidia (NVDA) Stock Gets Fair Value Trim As Analyst Views Turn More Divided Analyst downgrade Lawsuit AI-generated analysis
  • 📉 Fair value estimate trimmed from $328.72 to $319.99 reflecting cautious stance.
  • 🐂 Bull analysts maintain positive ratings citing strong AI demand and backlogs.
  • 🐻 Bear analysts lowered targets due to governance risks and succession uncertainty.